Accessibility Menu
 
Institute Of Biomedical Research logo

Institute Of Biomedical Research

(OTC) MRES

Current Price$0.00
Market Cap$4.12M
Since IPO (2005)-100%
5 Year-29%
1 Year-92%
1 Month-25%

Institute Of Biomedical Research Financials at a Glance

Market Cap

$4.12M

Revenue (TTM)

$46.96K

Net Income (TTM)

$1.65M

EPS (TTM)

$-0.00

P/E Ratio

-2.50

Dividend

$0.00

Beta (Volatility)

0.55 (Low)

Price

$0.00

Volume

130,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

MRES News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Institute Of Biomedical Research

Industry

Life Sciences Tools and Services

Employees

5

CEO

Peter Jeffrey Robinson

Headquarters

Podgorica, 81000, ME

MRES Financials

Key Financial Metrics (TTM)

Gross Margin

37%

Operating Margin

-11%

Net Income Margin

-35%

Return on Equity

-45%

Return on Capital

-21%

Return on Assets

-51%

Earnings Yield

-40.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.12M

Shares Outstanding

2.75B

Volume

130.00K

Avg. Volume

1.15M

Financials (TTM)

Gross Profit

$21.40K

Operating Income

$756.51K

EBITDA

$724.26K

Operating Cash Flow

$231.77K

Capital Expenditure

$7.50K

Free Cash Flow

$239.27K

Cash & ST Invst.

$11.80K

Total Debt

$0.00

Institute Of Biomedical Research Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$4.12M

N/A

Market Cap/Employee

$589.14K

N/A

Employees

7

N/A

Net Income

$31.28K

-119.7%

EBITDA

$55.34K

-139.6%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$3.58K

+1030.9%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-51.31%

N/A

Return on Invested Capital

-20.59%

N/A

Free Cash Flow

$5.18K

+94.7%

Operating Cash Flow

$5.18K

+94.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HSITFHadasit Bio-Holdings Ltd
$0.12+0.00%
ISCNFIsracann Biosciences Inc.
$0.00+0.00%
FNCHFinch Therapeutics Group, Inc.
$6.21-4.02%
CLYYFCelyad Oncology S.A.
$0.25+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About MRES

What is the current price of Institute Of Biomedical Research?

Institute Of Biomedical Research is trading at $0.00 per share.

What is the 52-week range for Institute Of Biomedical Research?

Over the past 52 weeks, Institute Of Biomedical Research has traded between $0.00 and $0.02.

How much debt does Institute Of Biomedical Research have?

As of the most recent reporting period, Institute Of Biomedical Research reported total debt of N/A.

How much cash does Institute Of Biomedical Research have on hand?

Institute Of Biomedical Research reported $3,585 in cash and cash equivalents in its most recent financial results.

What is Institute Of Biomedical Research’s dividend yield?

Institute Of Biomedical Research does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.